FDA Inspection
3M Company - Health Care Business3M Company - Health Care Business – FDA Inspection, Feb 11, 2019
Record Details
This FDA Inspection record concerns 3M Company - Health Care Business, with an inspection on February 11, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 74e1eadc-5192-45c0-88b5-7b7121363146
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1081355
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(c)(2)Failure to report non-alert ADEs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of 3M Company - Health Care Business
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | Not classified | Minneapolis District Office | |
| December 21, 2017 | Not classified | Minneapolis District Office | |
| June 16, 2017 | Not classified | Minneapolis District Office | |
| May 17, 2017 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| December 8, 2016 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for 3M Company - Health Care Business
- FDA Inspection 1228933 - 2025-02-07
- FDA Inspection 1051232 - 2017-12-21
- FDA Inspection 1030736 - 2017-06-16
- FDA Inspection 1017823 - 2017-05-17
- FDA Inspection 996493 - 2016-12-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.